GlassScriptPhysician profile
Stephen Reynolds
NPI 1245624683
$4,520.21
in general payments reported to CMS, 2019-2025
29 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $837 · 2020: $392 · 2021: $322 · 2022: $290 · 2023: $779 · 2024: $1,196 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,055 · Debt Forgiveness: $571 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,055.46 |
| Debt Forgiveness | $571.43 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $717.05 | 2020-2025 | |
| Photonicare INC | $571.43 | 2024 | Otosight Middle Ear Scope |
| Aerin Medical INC. | $475.95 | 2021-2025 | |
| Glaxosmithkline, LLC. | $441.39 | 2021-2025 | Nucala |
| Medical Device Business Services, INC. | $334.97 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $259.42 | 2022-2025 | Dupixent |
| Acclarent, INC | $222.37 | 2019-2023 | Trudi Nav Cable |
| Davol INC. | $213.81 | 2019-2020 | |
| Stryker Corporation | $186.89 | 2019-2025 | Audion Et Dilation System |
| Optinose US, INC. | $156.49 | 2020-2024 | |
| Intersect Ent, INC. | $123.38 | 2020-2021 | |
| Smith+Nephew, INC. | $119.03 | 2020 | |
| Cochlear Americas | $85.47 | 2019-2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Inspire Medical Systems, INC. | $81.85 | 2023-2024 | Inspire |
| Medtronic USA, INC. | $69.74 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Access Pro Medical, LLC | $59.15 | 2023 | Matriderm |
| Sanofi-Aventis U.S. LLC | $52.99 | 2023 | |
| Ethicon US, LLC | $52.65 | 2019-2021 | |
| Medtronic, INC. | $45.31 | 2022-2024 | Propel |
| Amgen INC. | $37.54 | 2025 | Tezspire |
| Alk-Abello, INC | $36.91 | 2022 | |
| Integra Lifesciences Corporation | $35.44 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| E.R. Squibb & Sons, L.L.C. | $34.84 | 2025 | Cobenfy |
| Hikma Pharmaceuticals USA | $23.13 | 2022 | |
| Organogenesis INC. | $22.52 | 2024 | |
| Acera Surgical, INC. | $18.58 | 2022 | |
| Merck Sharp & Dohme LLC | $18.37 | 2023 | |
| Abbvie INC. | $12.29 | 2019 | |
| Convatec INC. | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Reynolds listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.